Trius Therapeutics Inc
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY12 | FY11 | FY10 | FY09 | |
|---|---|---|---|---|
| Revenue | $9.8M | $2.7M | $8.0M | $5.0M |
| Operating income | −$57.2M | −$19.8M | −$20.7M | −$22.2M |
| Net income | −$53.9M | −$18.3M | −$23.9M | −$22.7M |
| Total assets | $75.3M | $68.1M | $49.5M | — |
| Total liabilities | — | — | — | — |
| Equity | $56.8M | $49.9M | $45.5M | −$51.5M |
| EPS (diluted) | $-0.22 | $-0.43 | $-2.36 | — |
| Shares out. | 38.6M | 28.7M | 23.6M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2012- Operating margin
- −582.1%
- Net margin
- −548.5%
- Return on equity
- −95.0%
- Return on assets
- −71.6%
- Return on capital (ROCE)
- −100.8%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $1.47
- Revenue growth (YoY)
- 262.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2012- Accruals / assets
- −5.9%clean
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 warning● 2 good- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Finn JohnOfficer — Chief Scientific Officer | Sep 11, 2013 | D | 3,230 | — |
| Eastham KarinDirector | Sep 11, 2013 | D | 6,000 | — |
| O'Leary BrendanDirector | Sep 11, 2013 | D | 21,302 | — |
| Schmid John P.Officer — Chief Financial Officer | Sep 11, 2013 | D | 107,639 | — |
| Truex Paul FDirector | Sep 11, 2013 | D | 11,270 | — |
| Bartizal KenOfficer — Chief Development Officer | Sep 11, 2013 | D | 96,400 | — |
| Prokocimer PhilippeOfficer — Chief Medical Officer | Sep 11, 2013 | D | 12,190 | — |
| Morneau MichaelOfficer — VP Finance & CAO | Sep 11, 2013 | D | 14,070 | — |
| Stein JeffreyOfficer — President & CEO | Sep 11, 2013 | D | 210,457 | — |
| Kabakoff David SDirector | Sep 11, 2013 | D | 5,285 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Unregistered equity sale · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsSep 11, 2013
- Results of operationsAug 6, 2013
- Entered a material agreementAug 1, 2013
- Entered a material agreementJul 25, 2013
- Director / officer change · Shareholder vote · Other material eventMay 24, 2013
- Results of operationsMay 7, 2013
- Director / officer changeApr 3, 2013
- Other material eventMar 25, 2013
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 14, 2014
- CT ORDEROct 10, 2013
- 15-12BSep 23, 2013
- EFFECTSep 16, 2013
- EFFECTSep 16, 2013
- 4FORM 4 SUBMISSIONSep 13, 2013
- 4FORM 4 SUBMISSIONSep 13, 2013
- 4FORM 4 SUBMISSIONSep 13, 2013
- 4FORM 4 SUBMISSIONSep 13, 2013
- 4FORM 4 SUBMISSIONSep 13, 2013
- 4FORM 4 SUBMISSIONSep 13, 2013
- 4FORM 4 SUBMISSIONSep 13, 2013
- 4FORM 4 SUBMISSIONSep 13, 2013
- 4FORM 4 SUBMISSIONSep 13, 2013
- 4FORM 4 SUBMISSIONSep 13, 2013